Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.
Duchenne muscular dystrophy (DMD) is caused by mutations in the gene that encodes the 427-kDa cytoskeletal protein dystrophin. Increased knowledge of the function of dystrophin and its role in muscle has led to a greater understanding of the pathogenesis of DMD. This, together with advances in the g...
主要な著者: | Nowak, K, Davies, K |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2004
|
類似資料
-
Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies
著者:: Yingyin Liang, 等
出版事項: (2015-05-01) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
著者:: Guiraud, S, 等
出版事項: (2019) -
Micro-dystrophin genes bring hope of an effective therapy for duchenne muscular dystrophy
著者:: Davies, K, 等
出版事項: (2019) -
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
著者:: Cedric Happi Mbakam, 等
出版事項: (2022-03-01) -
Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
著者:: Griffin, J, 等
出版事項: (2002)